Home
About Us
Overview
Management Team
Board of Directors
Medical and Scientific Advisors
Intellectual Property
Business Development
Partnerships
Careers
Total Rewards Program
Pipeline
Overview
Bavituximab Oncology
Cotara Oncology
Bavituximab Antiviral
Currently Enrolling Trials
Investigator-Sponsored Trials
Technology
Overview
Bavituximab Oncology
Mechanism of Action
Recent Additional Data
Bavituximab Antiviral
Mechanism of Action
PS-Targeting Data
Cotara Oncology
PS Imaging
PS Imaging Data
Publications
Biomanufacturing
Investors
Upcoming Events
News Releases
SEC Filings
Corporate Governance
Annual Reports
Corporate Fact Sheet
Stock Quote & Chart
Analyst Coverage
Investor FAQs
E-mail Alerts
Search the Site
Contact Us
|
Avid
|
Sitemap
Home
> Sitemap
Sitemap
Home
About Us
Overview
Management Team
Bio - Steven W. King
Bio - Paul J. Lytle
Bio - Joseph S. Shan, M.P.H.
Bio - Shelley P. M. Fussey, Ph.D.
Bio - Jeffrey L. Masten
Bio - Robert L. Garnick, Ph.D.
Bio - Kerstin B. Menander, M.D., Ph.D.
Steven Chamow, Ph.D.
Vladimir Evilevitch, M.D., Ph.D.
Bio - Mary J. Boyd, Ph.D.
Board of Directors
Medical and Scientific Advisors
Intellectual Property
Business Development
Partnerships
Careers
Total Rewards Program
Pipeline
Overview
Bavituximab Oncology
Cotara Oncology
Bavituximab Antiviral
Currently Enrolling Trials
Investigator-Sponsored Trials
Technology
Overview
Bavituximab Oncology
Mechanism of Action
Recent Additional Data
Bavituximab Antiviral
Mechanism of Action
PS-Targeting Data
Cotara Oncology
PS Imaging
PS Imaging Data
Publications
PS-Targeting Oncology Publications
PS-Targeting Antiviral Publications
Cotara Publications
Biomanufacturing
Investors
Upcoming Events
News Releases
SEC Filings
Corporate Governance
Annual Reports
Corporate Fact Sheet
Stock Quote & Chart
Analyst Coverage
Investor FAQs
E-mail Alerts
Copyright © 2003-2012 Peregrine Pharmaceuticals Inc., All Rights Reserved
Disclaimer
Safe Harbor